rofecoxib has been researched along with Arthralgia in 11 studies
Arthralgia: Pain in the joint.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This safety study compared the GI tolerability, the blood pressure (BP) profile and the incidence of oedema with lumiracoxib and rofecoxib in the treatment of OA." | 9.13 | A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients. ( Krammer, G; Stricker, K; Yu, S, 2008) |
| "To report a case of rofecoxib (Vioxx)-associated Stevens-Johnson syndrome with corneal and conjunctival changes." | 7.72 | A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes. ( Abelson, M; Barazi, M; Butrus, S; Goldberg, D; Panigrahi, D, 2004) |
| " This safety study compared the GI tolerability, the blood pressure (BP) profile and the incidence of oedema with lumiracoxib and rofecoxib in the treatment of OA." | 5.13 | A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients. ( Krammer, G; Stricker, K; Yu, S, 2008) |
| "Rofecoxib appears to control arthralgia in almost two-thirds of inflammatory bowel disease patients." | 5.11 | Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. ( Biancone, L; Emerenziani, S; Fina, D; Geremia, A; Pallone, F; Petruzziello, C; Tosti, C, 2004) |
| "To report a case of rofecoxib (Vioxx)-associated Stevens-Johnson syndrome with corneal and conjunctival changes." | 3.72 | A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes. ( Abelson, M; Barazi, M; Butrus, S; Goldberg, D; Panigrahi, D, 2004) |
| "Rofecoxib treatment, with its faster onset of OA efficacy and lower rates of related discontinuations, might provide efficacy advantages in the treatment of OA pain." | 2.71 | Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials. ( Battisti, WP; Geba, GP; Katz, NP; Kivitz, AJ; Matsumoto, AK; Polis, AB; Weaver, AL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ross, JS | 1 |
| Krumholz, HM | 1 |
| Angeby-Möller, K | 1 |
| Berge, OG | 1 |
| Hamers, FP | 1 |
| Stricker, K | 1 |
| Yu, S | 1 |
| Krammer, G | 1 |
| Déciga-Campos, M | 1 |
| López, UG | 1 |
| Reval, MI | 1 |
| López-Muñoz, FJ | 1 |
| Reinisch, W | 1 |
| Miehsler, W | 1 |
| Dejaco, C | 1 |
| Harrer, M | 1 |
| Waldhoer, T | 1 |
| Lichtenberger, C | 1 |
| Vogelsang, H | 1 |
| Biancone, L | 1 |
| Tosti, C | 1 |
| Geremia, A | 1 |
| Fina, D | 1 |
| Petruzziello, C | 1 |
| Emerenziani, S | 1 |
| Pallone, F | 1 |
| Goldberg, D | 1 |
| Panigrahi, D | 1 |
| Barazi, M | 1 |
| Abelson, M | 1 |
| Butrus, S | 1 |
| Battisti, WP | 1 |
| Katz, NP | 1 |
| Weaver, AL | 1 |
| Matsumoto, AK | 1 |
| Kivitz, AJ | 1 |
| Polis, AB | 1 |
| Geba, GP | 1 |
| Wilcox, GM | 1 |
| Mattia, AR | 1 |
| Bove, SE | 1 |
| Laemont, KD | 1 |
| Brooker, RM | 1 |
| Osborn, MN | 1 |
| Sanchez, BM | 1 |
| Guzman, RE | 1 |
| Hook, KE | 1 |
| Juneau, PL | 1 |
| Connor, JR | 1 |
| Kilgore, KS | 1 |
| Miller, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 6-Week Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Parallel Group Clinical Saftey Study to Evaluate Incidence of Predefined Gastrointestinal Adverse Events and Peripheral Edema in Subjects With Primary Osteoarthritis Treated W[NCT00637949] | Phase 3 | 309 participants (Actual) | Interventional | 2000-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for rofecoxib and Arthralgia
| Article | Year |
|---|---|
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
Topics: Aged; Arthralgia; Blood Pressure; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationshi | 2008 |
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.
Topics: Adult; Aged; Arthralgia; Arthritis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase In | 2003 |
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Colitis, Ulcerative; Crohn Disease | 2004 |
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Butano | 2004 |
7 other studies available for rofecoxib and Arthralgia
| Article | Year |
|---|---|
Bringing Vioxx back to market.
Topics: Arthralgia; Drug Approval; Hemophilia A; Humans; Lactones; Safety-Based Drug Withdrawals; Sulfones | 2018 |
Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib.
Topics: Analgesics; Analgesics, Opioid; Animals; Ankle Joint; Anti-Inflammatory Agents; Arthralgia; Arthriti | 2008 |
Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats.
Topics: Administration, Oral; Analgesics; Analgesics, Opioid; Animals; Arthralgia; Cyclooxygenase 2; Cycloox | 2003 |
A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes.
Topics: Arthralgia; Conjunctiva; Cornea; Cyclooxygenase Inhibitors; Female; Humans; Lactones; Middle Aged; S | 2004 |
Rofecoxib and inflammatory bowel disease: clinical and pathologic observations.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Biopsy; Colitis, Ulcerative; Colon | 2005 |
Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia.
Topics: Amines; Analgesics; Animals; Arthralgia; Cyclohexanecarboxylic Acids; Cyclooxygenase 2 Inhibitors; D | 2006 |
Decisions loom on selective COX-2 inhibitors.
Topics: Arthralgia; Arthritis; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Lacto | 1999 |